Results 171 to 180 of about 655,167 (267)

Publication Only

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Altered Pathogen Spectrum of Spontaneous Bacterial Peritonitis in Patients Treated With Proton Pump Inhibitors

Alimentary Pharmacology &Therapeutics, Volume 63, Issue 11, Page 1487-1494, June 2026.
This multicenter, observational study reveals distinct alterations in the microbial spectrum of spontaneous bacterial peritonitis (SBP) associated with proton pump inhibitor use. These results are especially relevant for guiding empiric antibiotic therapy of SBP.
Philip Kitchen, Sarah L. Schütte, Tammo L. Tergast, Benjamin Maasoumy, Leonie Braun, Ulrich vor dem Esche, Georg Häcker, Marcus M. Mücke, Marlene Reincke, Michael Schultheiss, Robert Thimme, Siegbert Rieg, Dominik Bettinger, Lukas Sturm   +13 more
wiley   +1 more source

Innovative Antibiotics: The Experience of Cefiderocol in Carbapenem-Resistant Gram-Negative Infections. [PDF]

Infect Drug Resist
Melchio M, Briano F, Sepulcri C, Vena A, Bassetti M.   +4 more
europepmc   +1 more source

Carbapenem Resistant Acinetobacter [PDF]

, 2020
openaire   +1 more source

Effects of Nacubactam and Its Metabolites on QTc Interval: A Pooled Analysis of Two Randomized Phase 1 Studies

Clinical and Translational Science, Volume 19, Issue 6, June 2026.
ABSTRACT Nacubactam is a β‐lactamase inhibitor. Early‐phase studies with 1000/2000/4000/8000 mg nacubactam monotherapy were not powered to assess proarrhythmic risk. Therefore, this analysis pooled electrocardiogram data from two placebo‐controlled studies to quantify potential effects of nacubactam on cardiac repolarization.
Jun Morita, Sue McKendrick, Yuji Kumagai
wiley   +1 more source

Characteristics of Carbapenem-Resistant <i>Enterobacterales</i> in the Chungcheong Region of Republic of Korea, 2024. [PDF]

Public Health Wkly Rep
Park J, Lee S, Kim Y.
europepmc   +1 more source

Exploring the Antimicrobial Efficacy of Mesenchymal Stem Cell Secretome Against Klebsiella pneumoniae in Urinary Tract Infections

Clinical and Translational Science, Volume 19, Issue 6, June 2026.
ABSTRACT Antimicrobial resistance (AMR) has become a global health crisis, with Klebsiella pneumoniae (K. pneumoniae) emerging as a major driver of AMR and a leading cause of urinary tract infections (UTIs). Mesenchymal stem cell (MSC)‐derived secretomes have gained attention for their antimicrobial properties.
Leen Ali, Elie Salem Sokhn, Charbel Khalil, Fatima A. Saleh   +3 more
wiley   +1 more source

Molecular Characterization and Risk Factors of Carbapenem-Resistant Hypervirulent Klebsiella pneumoniae Isolated from Chinese Tertiary Hospital

Rongping Zhu,1,* Ju Li,2,* Siyan Lian,2,* Yishan Li,3 Meili Cai,2 Yingping Cao,2 Xiaohong Xu2,4 1Department of Blood Transfusion, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fuzhou, Fujian, 350001, People’s ...
Li Y, Li J, Cai M, Cao Y, Lian S, Zhu R, Xu X   +6 more
core  

Repurposing Fingolimod as an Antibacterial and Antibiofilm Agent against Carbapenem-Resistant <i>Acinetobacter baumannii</i>. [PDF]

ACS Omega
Jin HW, Bae JH, Youn HS, Eom YB.
europepmc   +1 more source

Burn Wound Infections With Staphylococcus aureus: Clinical Characteristics and Risk Factors for Methicillin‐Resistant Strains

International Wound Journal, Volume 23, Issue 6, June 2026.
ABSTRACT This study aimed to systematically delineate the clinical characteristics and identify the key risk factors associated with methicillin‐resistant Staphylococcus aureus (MRSA) infections in burn patients, thereby informing targeted preventive measures and therapeutic strategies.
Xiaolan Hong, Shaobo Zhou, Qinghua Cai, Yuanyuan Cai, Zhaohong Chen, Wanting Zhao, Yongjian Ye, Xubo Dai   +7 more
wiley   +1 more source